Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-18

Clinical Trial Update: High-cutoff Hemodialyzer to Reduce Chronic Inflammation in Hemodialysis Patients [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of Phase 2 and Phase 3 evaluations of a high-cutoff hemodialyzer intended to reduce chronic inflammation in pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • High-cutoff hemodialyzer

Snippet

Sponsor: Martin-Luther-Universität Halle-Wittenberg | Conditions: End Stage Renal Disease | Phase 2, Phase 3 | Status: COMPLETED